Noticias y vídeos - GlobeNewsWire

SAN CARLOS, Calif., March 30, 2025 (GLOBE NEWSWIRE) -- Vaxcyte, Inc. (Nasdaq: PCVX), a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases, today announced it will hold a webcast and conference call tomorrow, March 31, 2025, at 8:00 a.m. Eastern Time to present topline results from the VAX-24 infant Phase 2 study. This study is evaluating the safety, tolerability and immunogenicity of VAX-24, the...

The Slovak authorities have confirmed an outbreak of Foot and Mouth Disease (FMD) on 30 March 2025 in a livestock of 3,487 animals on FirstFarms’ farm in Plavecký Stvrtok, Slovakia. The Slovak authorities have activated their outbreak contingency plan, which includes, among other things, the closure and isolation of the farm and the establishment of restriction zones. This is done to limit the risk of infection spreading. FirstFarms is working closely with the authorities to prevent the...

Please refer to the attached forms of notification of transactions by primary insiders under the DNO ASA Employee Synthetic Share Program. This notification has been submitted pursuant to the Norwegian Securities Trading Act § 5-12 and MAR Article 19 no. 3. Attachments Form of Notification Award of synthetic shares Erlend Wollan Einum March 2025 Form of Notification Award of synthetic shares Linn Hoel March 2025 Form of Notification Award of synthetic shares Haakon Sandborg March 2025 Form of...

On 30 March 2025, FirstFarms has seen possible symptoms of Foot and Mouth Disease (FMD) in one animal in a livestock of 3,487 animals on FirstFarms’ farm in Plavecky Stvrtok, Slovakia. The local authorities have been contacted, and the state veterinarian has carried out tests on the cow, the results of which are not yet available. FirstFarms has for now no further comments. FirstFarms will provide further information when the results are available. Foot and mouth disease is one of the most...

BEIJING, March 30, 2025 (GLOBE NEWSWIRE) -- BYD Energy Storage, a business division of BYD Company Limited, as a provider of renewable energy solutions, unveiled on March 26 th its next-gen commercial and industrial (C&I) energy storage system, Chess Plus, designed to address challenges in safety, efficiency, and profitability amid a fiercely competitive market. BYD Energy Storage’s Chess Plus establishes a new paradigm in energy storage through its cell-to-system (CTS) protection framework....

GUANGZHOU, China, March 30, 2025 (GLOBE NEWSWIRE) -- EHang (Nasdaq: EH), the world’s leading Urban Air Mobility (UAM) technology platform company, announced that its wholly-owned subsidiary, Guangdong EHang General Aviation Co., Ltd. (“EHang General Aviation”), and its joint venture company in Hefei, Hefei HeYi Aviation Co., Ltd. (“HeYi Aviation”), have been granted the first batch of Air Operator Certificates (“OC”) for civil human-carrying pilotless aerial vehicles by the Civil...

CUPERTINO, Calif., March 30, 2025 (GLOBE NEWSWIRE) -- Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH), a late-stage pharmaceutical company developing therapies that seek to address unmet medical needs in the areas of central nervous system (CNS), inflammatory and cardiometabolic diseases, announced today topline data from the long-term open label extension portion of the Phase 3 RECOVER study evaluating brilaroxazine in schizophrenia will be presented as part of an oral presentation at the...

Kaldalón hf. hereby announces that its Annual General Meeting will be held on Thursday, April 3, 2025, at 16:00 . The meeting will take place at Reykjavík Natura , Nauthólsvegur 52, 101 Reykjavík. Please note that the meeting will be conducted in Icelandic. The deadline to submit candidacies for the Board of Directors has passed. The following individuals have declared their candidacy for the Board of Directors of Kaldalón hf.: Álfheiður Ágústsdóttir Ásgeir Helgi Reykfjörð Gylfason...

HOUSTON, March 29, 2025 (GLOBE NEWSWIRE) -- Koil Energy Solutions, Inc. (OTCQB: KLNG), (the “Company”) today announced that it will be filing its Annual Report on Form 10-K for the fiscal year ended December 31, 2024, with the Securities and Exchange Commission (the “SEC”) later than the originally scheduled date of March 31, 2025. The Company anticipates filing the Annual Report within the extended timeframe granted by the SEC of fifteen days. The delay is due to the requirement to...

– Lorundrostat 50 mg dose achieved a 15.4 mmHg absolute reduction and 7.9 mmHg placebo-adjusted reduction (p=0.001), assessed by 24hr ABPM at week 12, with favorable safety and tolerability profile – – Lorundrostat is a highly selective aldosterone synthase inhibitor that disrupts aldosterone biosynthesis rather than blocking the mineralocorticoid receptor – – Data from Advance-HTN support the potential of lorundrostat as a best-in-class treatment for high-risk patients with...

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES TORONTO, March 28, 2025 (GLOBE NEWSWIRE) -- Helios Fairfax Partners Corporation (TSX: HFPC.U) today announced its financial results for the year ended December 31, 2024. All dollar amounts in this news release are expressed in U.S. dollars except as otherwise noted. The financial results are derived from the consolidated financial statements prepared using the recognition and measurement requirements of...

SHANGHAI, March 28, 2025 (GLOBE NEWSWIRE) -- Shanghai Junshi Biosciences Co., Ltd (“Junshi Biosciences,” HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced its financial results for the full year of 2024 and provided corporate updates. FINANCIAL HIGHLIGHTS Total revenue of Junshi Biosciences was approximately RMB1,948 million in 2024, representing an increase of...

SAN DIEGO, March 28, 2025 (GLOBE NEWSWIRE) -- Turnstone Biologics Corp. (“Turnstone” or the “Company”) (Nasdaq: TSBX), a biotechnology company historically focused on the development of a differentiated approach to treat and cure patients with solid tumors by pioneering selected tumor-infiltrating lymphocyte (“Selected TIL”) therapy, today announced its financial results for the fourth quarter and full year ended December 31, 2024, and provided recent corporate updates. Corporate...

(All dollar amounts are expressed in Canadian dollars, unless stated otherwise) MONTREAL, March 28, 2025 (GLOBE NEWSWIRE) -- Osisko Development Corp. (NYSE: ODV, TSXV: ODV) (" Osisko Development " or the " Company ") reports its financial and operating results for the three and twelve months ended December 31, 2024 (" Q4 2024 "). Q4 2024 HIGHLIGHTS Operating, Financial and Corporate Updates: As of December 31, 2024, the Company had approximately $106.7 million in cash and cash equivalents....

VANCOUVER, British Columbia, March 28, 2025 (GLOBE NEWSWIRE) -- HYTN Innovations Inc. (CSE: HYTN, FSE: 85W0, OTC PINK: HYTNF) ("HYTN" or the "Company"), a leader in pharmaceutical-grade cannabis manufacturing, is pleased to announce it has entered into strategic supply agreements (the “Agreements”) and successfully completed vendor qualification with two cannabis cultivators under its Good Manufacturing Practice (GMP) system qualifying a minimum of 4000 kg of cannabis for the German market....

TORONTO, March 28, 2025 (GLOBE NEWSWIRE) -- Partners Value Investments L.P. (the “Partnership”, TSX: PVF.UN TSX:PVF.PR.U) announced today its financial results for the year ended December 31, 2024. All amounts are stated in U.S. dollars. The Partnership recorded net income of $74 million for the year ended December 31, 2024, compared to $15 million in the prior year. The increase in income was primarily driven by higher investment income and valuation gains as well as foreign currency gains....

TORONTO, March 28, 2025 (GLOBE NEWSWIRE) -- Partners Value Split Corp. (the “Company”, TSX: PVS.PR.G, PVS.PR.H, PVS.PR.I, PVS.PR.J, PVS.PR.K, PVS.PR.L) announced today that the net asset value per unit was $171.41 at December 31, 2024 (December 31, 2023 – $124.10). All amounts are in U.S. dollars. Income available for distribution for the year ended December 31, 2024, was $85 million, compared to $73 million in the prior year. The increase in income was primarily attributable to the...

TORONTO, March 28, 2025 (GLOBE NEWSWIRE) -- Partners Value Investments Inc. (the “Company”, TSX: PVF.WT, PVF.PR.V) announced today its financial results for the year ended December 31, 2024. All amounts are stated in U.S. dollars. The Company recorded net loss of $3.8 billion for the year ended December 31, 2024, compared to $333 million in the prior year. The decrease in income was primarily attributable to the current year remeasurement losses associated with the retractable shares and...

SPOKANE, Wash., March 28, 2025 (GLOBE NEWSWIRE) -- Avista (NYSE: AVA) , the Staff of the Public Utility Commission of Oregon (Commission), the Oregon Citizens’ Utility Board (“CUB”), Alliance of Western Energy Consumers (“AWEC”), and the joint intervenor Climate Solutions/Green Energy Institute at Lewis & Clark Law School, parties to the Company’s natural gas general rate case, have reached a settlement agreement that has been submitted to the Commission for its consideration, and...

MONTREAL, March 28, 2025 (GLOBE NEWSWIRE) -- Senvest Capital Inc. today reported net income attributable to common shareholders of $258.1 million or $105.06 per share for the year ended December 31, 2024. This compares to net income attributable to common shareholders of $83.6 million or $33.78 per share for the year 2023. Financial statements are available online at Sedar www.sedarplus.ca CONSOLIDATED STATEMENTS OF INCOME (in millions of dollars, except per share amounts) For the years ended...